Who is sponsoring NCT04815382?

NCT04815382 is sponsored by Universidad de Burgos.

What drugs are being tested in NCT04815382?

Interventions in NCT04815382: Dynamic Upper Limb Orthosis.

What condition does NCT04815382 study?

NCT04815382 studies Parkinson Disease, Tremor, Limb, Rigidity, Muscle.

Is NCT04815382 still recruiting?

NCT04815382 is currently status unknown. Last updated 27 June 2022.

Last reviewed 2022-06-27 · How we verify

NCT04815382

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Dynamic Upper Limb Orthosis in Patients With Parkinson's Disease

Status unknown NA Last updated 27 June 2022

What this trial tests

NA trial testing Dynamic Upper Limb Orthosis in Parkinson Disease in 40 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
1 October 2022

30 April 2023

Quick facts

Lead sponsor	Universidad de Burgos
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	1 January 2021
Primary completion	1 October 2022
Estimated completion	30 April 2023
Sites	1 location across Spain

Drugs / interventions tested

Dynamic Upper Limb Orthosis

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →
Tremor, Limb — all drugs for Tremor, Limb →
Rigidity, Muscle — all drugs for Rigidity, Muscle →

Sponsor

Universidad de Burgos

Who can join

Adults 18 to 99, any sex, with Parkinson Disease or Tremor, Limb. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled clinical trial aimed at Parkinson's disease patients. Its objective is to evaluate the effects of a dynamic upper limb orthosis to achieve maximum hand functionality, reducing tremor and rigidity

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Functionality and Quality of Life with Parkinson's Disease after Use of a Dynamic Upper Limb Orthosis: A Pilot Study.
Jiménez-Barrios M, González-Bernal J, Cubo E, Gabriel-Galán JM, et al · · 2023 · cited 4× · PMID 36981905 · DOI 10.3390/ijerph20064995

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Universidad de Burgos trials

Trials by the same sponsor.

NCT07275996 — Neuromuscular and Multi-Omics Synergy of Combined Creatine × HMB Supplementation Plus Exercise to Improve Muscle Functio · NA · not yet recruiting
NCT07213063 — Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Musc · NA · recruiting
NCT06909994 — Daily Living Activities in Young Adults With Cerebral Palsy · completed
NCT06638775 — Functional Electrostimulation on the Upper Lip in Multiple Sclerosis · NA · not yet recruiting
NCT05951439 — Effect of Creatine+HMB Supplementation in Physically Active Older Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04815382 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Burgos
Last refreshed: 27 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04815382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing